Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast ...